NVOXLVUNH The sector hasn't been in favor lately, but it is far from going away. While the technical on many names are still bearish, this could be an ideal time to rotate some profits from the recent rally into healthcare. Demand for healthcare is only going to increase, and this might be a smart long-term move while valuations are still discounted.
NVO getting 9th of September 24' vibes on the price movement. On all good news 1% up 2% down. It doesn't add up to me. Retailers gotta want a better price. #Sell
NVOLLYXLV Cutting prices would slow the pharmaceutical industry’s pace of innovation, which is why I believe they won’t be reduced; instead, other countries will eventually raise their prices to offset any cost cuts in the U.S.
NVOLLY Trump just said that prices will not be cut; rather, they will be redistributed so that the topline remains unaffected, and the U.S. will negotiate drug prices with other countries.
NVOLLY Trump already attempted to cut pharmaceutical prices in his last term, and faced legal pushback from pharma lobbyists. It’s just a stunt to distract people from rising prices caused by baseline tariffs. if you sale to this news you wont make money, its just a short-term noise just like the tariffs